It looks like most of the activity in the next six months will be regulatory.
There might be some trial data- they mentioned STARLITE in the AGM presentation and also the ZIPUP trial may be in the works. Most of the other trial stuff looks like it will come in 2025-6
However things that could (and in some cases should) happen in the next six months:
Approvals for Illucix in other jurisdictions: EU, UK, Brazil? Japan?
Approval for Zicaux in US
Submission of Pixclara.
ProstACT expanding into the US.
It still looks like imaging will drive revenue growth until at least the the end of 2026- and if things go well that should be enough to at least double current revenues. While CB (understandably) pushes the therapy line, it looks like that will take a bit of time yet.
Short Term trading, analysis and TLX noise - No investors keep out, page-550
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.90 |
Change
-0.010(0.04%) |
Mkt cap ! $7.664B | |||
| Open | High | Low | Value | Volume |
| $23.00 | $23.19 | $22.40 | $16.31M | 715.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3391 | $22.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.93 | 2866 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |